Pick C G, Peter Y, Terkel J, Gavish M, Weizman R
Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, Israel.
Psychopharmacology (Berl). 1996 Nov;128(1):61-6. doi: 10.1007/s002130050110.
This study examined the effect of the neuroactive steroid 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (alpha-THDOC) as compared to the benzodiazepines diazepam and midazolam and the barbiturate phenobarbital on the number of rearing events and the number of steps ascended in the mouse staircase test. The benzodiazepines, phenobarbital and alpha-THDOC all reduced rearing activity at doses that did not affect climbing. The rearing-suppression effect of the benzodiazepines and alpha-THDOC, but not of phenobarbital, was blocked by the benzodiazepine antagonist flumazenil. It appears that, although such neuroactive steroids, like barbiturates, bind to distinct sites within the chloride ion channel of the gamma-aminobutyric acid type A (GABAA) receptor complex, alpha-THDOC behavioral activity is modulated by the benzodiazepine recognition site.
本研究考察了神经活性甾体3α,5α-四氢脱氧皮质酮(α-THDOC)与苯二氮䓬类药物地西泮和咪达唑仑以及巴比妥类药物苯巴比妥相比,对小鼠阶梯试验中竖毛事件数量和攀爬步数的影响。苯二氮䓬类药物、苯巴比妥和α-THDOC在不影响攀爬的剂量下均降低了竖毛活动。苯二氮䓬类药物和α-THDOC的竖毛抑制作用,但苯巴比妥的没有,被苯二氮䓬类拮抗剂氟马西尼阻断。似乎,尽管这类神经活性甾体与巴比妥类药物一样,与γ-氨基丁酸A型(GABAA)受体复合物氯离子通道内的不同位点结合,但α-THDOC的行为活性受苯二氮䓬类识别位点调节。